Australia's Therapeutic Goods Administration (TGA) joins World Wide Web:
This article was originally published in Clinica
Executive Summary
Australia's regulatory agency, the Therapeutic Goods Administration, now has a site on the Internet. The site features information of interest to the devices industry on the TGA's activities, as well as therapeutic devices incident reports (which can be lodged online), relevant Australian legislation and TGA publications. The TGA site is located at http://www.health.gov.au/hsh/tga/tga.htm.
You may also be interested in...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.
England’s NICE Says No To Santhera’s DMD Drug Agamree Due To ‘Unreliable Modeling’
Santhera Pharmaceuticals did not provide enough evidence to demonstrate that its Duchenne muscular dystrophy drug Agamree was a cost-effective use of resources, according to draft guidance from England’s health technology assessment body, NICE.